邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

我国临床生物样本库平台化建设

黄平,  冯变莹,  穆迪,  周浩,  姚祖德,  满秋红

downloadPDF
文章导航 > 协和医学杂志  > 2020 >  11(6): 754-757
黄平, 冯变莹, 穆迪, 周浩, 姚祖德, 满秋红. 我国临床生物样本库平台化建设[J]. 协和医学杂志, 2020, 11(6): 754-757. doi: 10.3969/j.issn.1674-9081.2020.06.021
引用本文: 黄平, 冯变莹, 穆迪, 周浩, 姚祖德, 满秋红. 我国临床生物样本库平台化建设[J]. 协和医学杂志, 2020, 11(6): 754-757. doi: 10.3969/j.issn.1674-9081.2020.06.021
shu
HUANG Ping, FENG Bian-ying, MU Di, ZHOU Hao, YAO Zu-de, MAN Qiu-hong. Characteristics and Development of Platform Construction of Clinical Biobank in China[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 754-757. doi: 10.3969/j.issn.1674-9081.2020.06.021
Citation: HUANG Ping, FENG Bian-ying, MU Di, ZHOU Hao, YAO Zu-de, MAN Qiu-hong. Characteristics and Development of Platform Construction of Clinical Biobank in China[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 754-757. doi: 10.3969/j.issn.1674-9081.2020.06.021
shu

我国临床生物样本库平台化建设

doi: 10.3969/j.issn.1674-9081.2020.06.021

  • 同济大学附属上海市第四人民医院检验科，上海 200081

基金项目: 

国家重大研发计划 2016YFF0202301

详细信息
    通讯作者:

    满秋红  电话：13161508773, E-mail:Manqiuhong307@163.com

  • 中图分类号: R446.9

Characteristics and Development of Platform Construction of Clinical Biobank in China

  • Department of Clinical Laboratory, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai 200081, China

More Information

    摘要
  • 摘要: 医学研究迫切需要大量有价值的生物样本和数据资源集成共享来破解重大疾病难题。在医疗实践和医学研究过程中，临床生物样本库发挥了科研服务支撑平台作用，通过整合有限的生物样本与数据资源，为探索疾病发生、发展、转归、诊断、治疗及药物研发和健康预防等提供资源保障。本文着重阐述我国临床生物样本库平台标准化建设特点与发展、公共管理平台运行模式、信息化平台与资源平台运行管理及质量控制，以期推动我国临床生物样本库平台化、标准化建设。
    Abstract: Medical research urgently needs to integrate and share a large number of valuable biological samples and data resources to solve difficult problems in major diseases. In medical institutions, the clinical biological sample database plays the role of service-supporting platform for scientific research, which integrates limited biological samples and corresponding data to provide resource guarantee for the exploration of disease occurrence, development, transition, diagnosis, treatment, drug development and health prevention. In this paper, the characteristics and contents of standardized construction of clinical biobank platforms in China, the collaborative management mode of public management platforms, and the operation content and quality control of resource platforms were emphatically expounded. The purpose of this paper is to promote the standardized system construction of platforms of clinical biological sample database in China.
    利益冲突  无
    • HTML全文
    • 参考文献(19)
  • [1] Coppola L, Cianflone A, Grimaldi AM, et al. Biobanking in health care: evolution and future directions[J]. J Transl Med, 2019, 17:172. doi:  10.1186/s12967-019-1922-3
    [2] Quinlan PR, Groves M, Jordan LB, et al. The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network[J]. Biopreserv Biobank, 2015, 13: 363-370. doi:  10.1089/bio.2014.0099
    [3] 满秋红, 于农, 闫飞, 等.我国生物样本库建设现状与未来发展的思考[J].中国医药生物技术, 2018, 13: 289-293. doi:  10.3969/j.issn.1673-713X.2018.04.001
    [4] 徐艳, 樊萍, 胡迅.生物样本库建设的关键问题及解决策略[J].华西医学, 2018, 33: 651-654.
    [5] 郜恒骏, 杜莉利, 张小燕, 等.生物样本库发展的现状、机遇与挑战[J].协和医学杂志, 2018, 9: 172-176. doi:  10.3969/j.issn.1674-9081.2018.02.013
    [6] 翟培军, 李军燕, 胡冬梅, 等.生物样本库国际认可和标准化发展与前景[J].中华临床实验室管理电子杂志, 2017, 5: 6-8. doi:  10.3877/cma.j.issn.2095-5820.2017.01.003
    [7] Haga SB, Beskow LM. Ethical, legal, and social implica-tions of biobanks for genetics research[J]. Adv Genet, 2008, 60: 505-544. doi:  10.1016/S0065-2660(07)00418-X
    [8] Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality[J]. Pharmacogenomics, 2005, 6: 639-646. doi:  10.2217/14622416.6.6.639
    [9] Fearn P, Michels C, Meagher K, et al. 2012 International Society for Biological and Environmental Repositories Informatics Working Group: survey results and conclusions[J]. Biopreserv Biobank, 2013, 11: 64-66. doi:  10.1089/bio.2012.1115
    [10] Vaught J. Biobanking Comes of Age: The Transition to Biospecimen Science[J]. Annu Rev Pharmacol Toxicol, 2016, 56: 211-228. doi:  10.1146/annurev-pharmtox-010715-103246
    [11] Quinlan PR, Gardner S, Groves M, et al. A Data-Centric Strategy for Modern Biobanking[J]. Adv Exp Med Biol, 2015, 864: 165-169.
    [12] De Souza YG, Greenspan JS.Biobanking past, present and future: responsibilities and benefits[J]. AIDS, 2013, 27: 303-312. doi:  10.1097/QAD.0b013e32835c1244
    [13] Zhu S, Shen M, Qiu X, et al. Ethical management guidelines for the shanghai disease-based biobank network[J]. Biopreserv Biobank, 2015, 13: 8-12. doi:  10.1089/bio.2014.0087
    [14] Baker M. Biorepositories: Building better biobanks[J]. Nature, 2012, 486: 141-146. doi:  10.1038/486141a
    [15] Zamboni WC, Torchilin V, Patri AK, et al.Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance[J]. Clin Cancer Res, 2012, 18: 3229-3241. doi:  10.1158/1078-0432.CCR-11-2938
    [16] 郭丹, 杨文航, 徐英春.临床生物样本库信息系统建设与发展[J].协和医学杂志, 2018, 9: 81-86. doi:  10.3969/j.issn.1674-9081.2018.01.015
    [17] Rush A, Byrne JA. Quality and reporting practices in an Australian cancer biobank cohort[J]. Clin Biochem, 2016, 49: 492-497. doi:  10.1016/j.clinbiochem.2015.12.007
    [18] Betsou F, Sobel ME. The ISBER Biorepository proficiency testing program: two successful years already, and new features to come[J]. Biopreserv Biobank, 2013, 11: 255-256. doi:  10.1089/bio.2013.1143
    [19] Vaught J, Campbell LD, Betsou F, et al. The ISBER Best Practices: Insight from the Editors of the Third Edition[J]. Biopreserv Biobank, 2012, 10: 76-78. doi:  10.1089/bio.2012.1024
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  906
  • HTML全文浏览量:  317
  • PDF下载量:  61
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-06-05
  • 录用日期:  2019-07-17
  • 网络出版日期:  2019-07-23
  • 刊出日期:  2020-11-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！